Introduction
Nasopharyngeal carcinoma (NPC) is a highly malignant cancer derived from the nasopharyngeal epithelium. NPC has a particularly high incidence in Southeast Asia and Northern Africa, with a distinct ethnic predilection (Chou et al., 2008) . Accumulating evidence revealed that NPC is a multifactorial malignancy associated with Epstein-Barr virus (EBV) infection, genetic susceptibility and environmental factors (McDermott et al., 2001; Zeng and Jia, 2002; Wei and Sham, 2005; Bei et al., 2010) . Although NPC tumors are sensitive to radiotherapy and chemotherapy, the prognosis is poor due to recurrence and metastases. However, the precise molecular mechanism of its pathogenesis and progression is still largely unknown. Better understanding of the cellular and molecular mechanisms of its pathogenesis and progression is essential for the development of novel strategies for the diagnosis and treatment of NPC.
MicroRNAs (miRNAs) belong to a class of conserved endogenous non-coding small RNAs, which negatively regulate gene expression at the post-transcriptional level by annealing with the 3 0 -untranslated region (3 0 UTR; Bartel, 2004; Valencia-Sanchez et al., 2006) . They are important regulators of basic cellular functions, including proliferation, migration, differentiation and apoptosis (Felli et al., 2005; Esquela-Kerscher and Slack, 2006; Fontana et al., 2007; He et al., 2007; Wang et al., 2007) . Many types of human disease, especially cancer, have been linked to a deregulation of the expression of miRNAs (Calin et al., 2004) . To date, several groups have suggested that human endogenous miRNAs are associated with oncogenesis and tumor progression in NPC. MiR-29c is downregulated in NPC and regulates genes encoding extracellular matrix proteins (Sengupta et al., 2008) . MiR-26a has been reported to suppress cell proliferation and tumorigenesis of NPC through repression of EZH2 (Lu et al., 2011) . MiR-218 can cause significant toxicity in NPC cells and delay tumor growth, as well as regulate NPC cell migration through downregulation of survivin and the SLIT2-ROBO1 pathway (Alajez et al., 2011) . Expression levels of 35 miRNAs have been found to be significantly altered in NPC and these miRNAs target several oncogenic pathways in NPC . Moreover, human miRNAs, such as miR-141, miR-200a, let-7, miR-100 and several EBV-encoded miRNAs, including miR-BART5 and miR-BART22, have been shown to be aberrantly expressed and to contribute to the development and progression of NPC (Choy et al., 2008; Lung et al., 2009; Shi et al., 2010; Xia et al., 2010; Zhang et al., 2010; Wong et al., 2011 ).
MiR-663, which is located at human chromosome 20q11.1, is associated with cellular senescence, immunity and cancer (Lehmann et al., 2007; Pizzimenti et al., 2009; Pan et al., 2010) . MiR-663 is upregulated in replicative senescence in WI-38 human fibroblasts and is correlated with the repression of Id1, as well as insulinlike growth factor 1 receptor (Maes et al., 2009) . A research of global changes in miRNAs between earlypassage and senescent WI-38 human diploid fibroblasts showed that miR-663 is markedly more abundant in senescent cells (Marasa et al., 2010) . Furthermore, miR-663 was identified to be differentially expressed in experiments using EBV-transformed B-cell lines and peripheral blood mononuclear cells obtained from lupus nephritis affected patients, suggesting that it is associated with lupus nephritis (Te et al., 2010) . It is upregulated by oscillatory shear stress and has a key role in oscillatory shear-induced inflammatory responses by mediating the expression of the inflammatory gene network in human umbilical vein endothelial cells (Ni et al., 2011) . In human THP-1 monocytic cells and human blood monocytes, resveratrol upregulates miR-663, which decreases endogenous activator protein-1 activity and impairs its upregulation by lipopolysaccharides by targeting Jun B and Jun D (Tili et al., 2010a) . Furthermore, it is involved in a resveratrolrelevant pathway by targeting transforming growth factor-b1 (Tili et al., 2010b) . This miRNA is increasingly thought to act as a tumor suppressor and has been shown to be downregulated in human gastric cancer cells and induce mitotic catastrophe growth arrest (Pan et al., 2010) . However, the role of miR-663 in NPC remains unknown.
Cip1/Waf1/Sdi1 (p21) is a member of the Cip/Kip family of cyclin-dependent kinase inhibitors. It has functions in multiple cellular processes, including differentiation, senescence, apoptosis, DNA replication and repair, cell proliferation and cell cycle arrest. The expression of p21 is likely to be tightly regulated at the transcriptional and post-transcriptional level. For example, at the post-translational level, p21 is mainly regulated by phosphorylation, localization and ubiquitination. We have recently demonstrated that nucleophosmin/B23 and hSSB1 may function as chaperones to protect p21 from degradation by the ubiquitin-proteasome pathway (Xiao et al., 2009; Xu et al., 2011) . Interestingly, miRNAs such as the miR-17 family and human pathogenic gamma herpes virus Kaposi's sarcoma-associated herpes virus miR-K1 have also been reported to regulate p21 expression negatively at the post-transcriptional level via the p21 3 0 UTR (Gottwein and Cullen, 2010; Wang et al., 2010) .
In this study, we generated a specific miRNA expression profile in NPC cells with the use of a miRNA microarray that contained 686 miRNAs. We demonstrated that miR-663 was upregulated in NPC cells. In these cells, miR-663 may function as an oncogene by promoting cell growth and tumorigenesis. Furthermore, p21 was characterized as a direct and functional target of miR-663. The newly identified miR-663/p21
axis elucidates the molecular mechanism of NPC cell proliferation and represents a novel strategy for the diagnosis and treatment of patients with NPC.
Results

MiR-663 is overexpressed in human NPC
As an initial step to establish a correlation between NPC tumorigenesis and miRNA gene expression, miRNA expression profiling was conducted with a miRNA microarray using RNA isolated from HONE1 and 5-8F cells, two NPC cell lines, and N5-Bmi-1, a human immortalized nasopharyngeal epithelial cell line (Song et al., 2006; Kong et al., 2010) . Overall, 686 miRNAs were detected in these cell lines, of which 27 were upregulated and 18 were downregulated in NPC cells compared with the immortalized epithelial cells (Figure 1a ). To our surprise, upregulation of miR-663, a miRNA recently identified to be a tumor suppressor in gastric cancer, was observed in NPC cells, which indicated that miR-663 may function differently in NPC cells.
To validate this unexpected finding, we then detected miR-663 expression in 12 tissue samples of human NPC and 12 samples of nasopharyngitis. Consistent with the data we observed in the NPC cell lines, the average expression level of miR-663 was significantly higher in the NPC specimens compared with the nasopharyngitis tissue samples (Po0.05; Figure 1b ).
MiR-663 promotes cell proliferation in vitro
The upregulation of miR-663 in NPC cells prompted us to examine its potential role in cell proliferation. As shown in Figure 2a , the growth rate was significantly decreased in both CNE1 and 5-8F cells as a result of the downregulation of miR-663 using a locked nucleic acid (LNA)-modified miR-663-specific anti-sense oligonucleotide (LNA anti-miR). This result suggested that miR-663 may promote the proliferation of NPC cells. This notion was further supported by the colony formation assay using both CNE1 and 5-8F cells in vitro (Figure 2c ).
To confirm this phenomenon, the miR-663 sponge plasmid vector was constructed to stably inhibit miR-663 (Supplementary Figures S1a and b) . Additionally, as shown in Figures 2b and d , both the cell growth and the clone formation were suppressed by the stable inhibition of miR-663 in both CNE1 and 5-8F cells. As shown in Supplementary Figure S2 , proliferation was promoted by transfecting both CNE1 and 5-8F cells with a precursor miR-663 oligonucleotide (pre-miR-663) .
In addition, to investigate the effect of miR-663 on proliferation of NP69 cells (a human immortalized nasopharyngeal epithelial cell line), a cell proliferation assay was performed after miR-663 was overexpressed in the cells. As shown in Supplementary Figure S3 , miR-663 dramatically promoted the cell growth and clone formation in NP69 cells.
Collectively, our results indicate that miR-663 may promote the proliferation of both NPC cells and non-tumor-derived cells in vitro.
MiR-663 regulates cellular G1/S transition As miR-663 promotes cell proliferation of NPC cells in vitro, we tested whether it affects the cell cycle profile in NPC cells. As shown in Figures 3a and b , the percentage of cells in the G1 phase was increased after the transfection of miR-663 LNA or miR-663 sponge vectors in both CNE1 and 5-8F cells. A decrease of the percentage of cells in the G1 phase was observed after transfection of pre-miR-663 in NP69 cells (Supplementary Figure S7a) . However, the cell cycle profile was marginally altered by the overexpression of miR-663 in NPC cells (Supplementary Figure S4a) . The endogenous miR-663 level may have been high enough to execute its functions in NPC cells (Figure 4d ). Furthermore, after cells were synchronized by serum starvation, we further detected that the percentage of cells that re-entered Sphase after serum stimulation was less when miR-663 was inhibited by LNA anti-miR or miR-663 sponge vectors in both CNE1 and 5-8F cells (Figures 3c and d) . When the same serum-starvation stimulation assay was used to compare cells that were transfected with pre-miR-663 and controls, there was no apparent difference in the percentage of CNE1 and 5-8F cells entering the S-phase between the experimental and control cells (Supplementary Figure S4b) . These results suggest that miR-663 may enhance cell proliferation by promoting the G1/S transition.
p21 is a direct target of miR-663 p21 is one of the key regulators of G1/S transition. Interestingly, we found two putative binding sites for miR-663 at 664-670 and 132-138 in the 3 0 UTR of p21, with the use of two online algorithms, Target Scan and microrna.org (Figure 4a) . Indeed, as shown in Figure 4b , pre-miR-663 was efficient in downregulating the luciferase activity of p21-3 0 UTR-wt, but not of p21-3 0 UTR-mt, in which two putative binding sites for miR-663 were individually or jointly mutated. Moreover, as expected, upregulation of miR-663 caused a significant decrease of p21 expression at both mRNA and protein levels in CNE1, 5-8F and NP69 cells (Figure 4c and Supplementary Figure S7b) . Consistently, an obvious increase of endogenous p21 was observed by either the transient or stable inhibition of miR-663 in both CNE1 and 5-8F cells (Figure 4c and Supplementary Figure  S1c) . To further confirm that the effects of miR-663 were specifically due to the downregulation of p21 through its 3 0 UTR, we overexpressed miR-663 along with a p21 construct lacking its 3 0 UTR and thus, unresponsive to inhibition by the miRNA. As expected, overexpression of the p21 construct rescued the increased proliferation phenotype and the decreased percentage of cells in the G1 phase in the miR-663-transfected NP69 cells (Supplementary Figure S9) . However, alteration of p21 localization was not observed by immunofluorescence after overexpression and knockdown of miR-663 (Supplementary Figure S5) . We further analyzed the endogenous expression levels of miR-663 and p21 in NPC cell lines. Quantitative realtime RT-PCR analyses revealed that miR-663 was markedly upregulated in NPC cell lines when compared with N5-Bmi-1 or NP69 (Figure 4d ). Protein expression levels for p21 were downregulated in NPC cell lines compared with N5-Bmi-1 and NP69 ( Figure 4e ). Our results reveal an inverse relationship between high expression of miR-663 and low expression of p21 in NPC cells.
However, no inverse correlation was observed between miR-663 and p21 in the 12 samples of NPC tissues Figure S6) . We speculated that p21 may be controlled by various mechanisms in the human tissues, especially in different conditions of diseases such as cancer or inflammation.
p21 is involved in miR-663-regulated G1/S transition Next, we examined the role of p21 in the miR-663-regulated G1/S transition. The percentage of cells at G1 phase was decreased when p21 was singly knocked down (Supplementary Figure S4c) . More importantly, both the transient and stable inhibition of miR-663 resulted in the lack of cells accumulating in the G1 phase after p21 was silenced by siRNA in both the CNE1 and 5-8F cell lines (Figures 5a and b ). This finding indicates that the promotion of the G1/S transition by miR-663 is dependent on p21.
Furthermore, to detect alteration of expression of the p21 pathway proteins after inhibition or overexpression of miR-663 in CNE1 and NP69 cells, we characterized phosphorylated-Rb protein (ppRb), total Rb protein (pRb), E2F1, cyclin E, cyclin A and p27 at the RNA and protein levels (Figures 5c and d and Supplementary Figure S7 ). Expressions of ppRb and E2F1 changed inversely with p21 expression after inhibition or overexpression of miR-663 in CNE1 or NP69 cells. Reductions of ppRb and E2F1 expression and an increase of p21 expression were observed Figure S7) . However, cyclin E and cyclin A were not observed to change at the RNA or protein levels. As p21 regulates the G1/S transition by activating cyclin-dependent kinases and cyclin complexes, it is reasonable that expression of the cyclins may not change during the dissociation. Another key regulator of the G1/S transition, p27, was not altered with overexpression and inhibition of miR-663 or silencing of p21 ( Figure 5 and Supplementary Figure S7 ). Together, these results suggest that miR-663 promotes the G1/S transition through the p21-pRb pathway in both NPC cells and non-tumor-derived cells.
Inhibition of miR-663 suppresses tumor growth in vivo As inhibition of miR-663 suppresses cell proliferation of NPC cells in vitro, we hypothesized that miR-663 may also have a similar action in vivo. After nude mice were injected with CNE1 cells stably transfected with miR-663 sponge (CNE1-sponge-663) or control sponge (CNE1-NC), respectively, we found that tumors grew at a slower rate and had smaller sizes when miR-663 was inhibited in this animal model of tumorigenicity (Figures 6a-d) . Consistently, both the downregulation of Ki67 and the upregulation of p21 were observed in the tumors generated from the CNE1-sponge-663 vector compared with those generated from CNE1-NC according to the results of immunohistochemical analysis (Figure 6e ). These results indicate that inhibition of miR-663 may suppress tumor growth by upregulating p21 in vivo. 
Discussion
The abnormal expression of miRNAs has been reported in many types of cancer, and much attention has focused on understanding the roles of miRNAs in modulating the process of cancer development (Lu et al., 2005; Landgraf et al., 2007) . In this report, the specific miRNA expression profile of NPC cells was generated using a miRNA microarray that contained 686 miRNAs. Furthermore, miR-663 was determined to Figure 5 p21 is involved in miR-663-regulated transition from G1 to the S phase. (a) Knockdown of p21 rescues miR-663-LNAinduced G1 arrest. CNE1 and 5-8F cells were first transfected with the negative control or miR-663 LNA anti-miR for 24 h, followed by transfection with scrambled or p21 siRNA for 24 h. Cell cycle profiles were analyzed using fluorescence-activated cell sorting (FACS). (b) Knockdown of p21 rescues miR-663 sponge-induced G1 arrest. CNE1 and 5-8F cells stably expressing the miR-663 sponge or control sponge vectors were transfected with scrambled or p21 siRNA for 24 h. Cells were harvested and cell cycle profiles were analyzed using FACS. Data are from three independent experiments and expressed as means±s.d. (c) Expressions of p21, ppRb, pRb, E2F1, cyclin E, cyclin A and p27 were analyzed after co-transfection of miR-663 LNA anti-miR and p21 siRNA in CNE1 cells. CNE1 cells were first transfected with the negative control or miR-663 LNA anti-miR for 24 h, followed by transfection with scrambled or p21 siRNA for 24 h. Western blotting and RT-PCR were used to detect expressions of the indicated proteins and RNA, respectively. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and b-actin were internal controls for western blotting and RT-PCR, respectively. (d) Expressions of p21, ppRb, pRb, E2F1, cyclin E, cyclin A and p27 were analyzed after co-transfection of the miR-663 sponge vector and p21 siRNA in CNE1 cells. CNE1 cells stably expressing the miR-663 sponge or control sponge vector were transfected with scrambled control or p21 siRNA for 24 h, and western blotting and RT-PCR were used to detect expressions of the indicated proteins and RNA, respectively. GAPDH and b-actin were internal controls for western blotting and RT-PCR, respectively. (Felli et al., 2005; Esquela-Kerscher and Slack, 2006; Fontana et al., 2007; He et al., 2007; Wang et al., 2007) , the roles of miRNAs in cancer are consequently very complicated. A single miRNA may be upregulated in one type of cancer, but downregulated in another. For example, miR-125b is markedly downregulated in human breast cancers and breast cancer cell lines (Iorio et al., 2005) , whereas high levels of miR-125b have been detected in prostate cancer cell lines and clinical tissue samples (Shi et al., 2007) . Furthermore, from a largescale miRnome analysis including lung, breast, stomach, prostate, colon and pancreatic tumors, several miRNAs, such as miR-218-2, have also shown inconsistent expression in different human solid tumors from distinct organs (Volinia et al., 2006) . Recently, miR-663 was reported to be a tumor suppressor, which was decreased in human gastric cancer cell lines and acted to repress cell proliferation and tumor growth by inducing a mitotic catastrophe (Pan et al., 2010) . In this study, we also analyzed the function of miR-663 in two gastric cancer cell lines, MKN-45 and SCG-7901, and verified its role in repressing cell proliferation of the cell line MKN-45 (Supplementary Figure S8) . In contrast, we demonstrated that miR-663 may act as an oncogene in NPC cells by promoting the G1/S transition via directly targeting p21. The functions of some miRNAs, such as miR-125b, miR-218-2 and miR-663, need to be determined individually in each cancer type, as they may act as tumor suppressors or oncogenes in a cell-specific context.
As a critical cell cycle regulator, p21 was found to be directly regulated by miR-663 at the post-transcriptional level in the present study. It was recently reported that p21 is directly regulated by multiple miRNAs. Members of the miR-106b and miR-17-92 families modulate p21 expression in different cell types and are involved in multiple cellular processes, including cell cycle transition, cell proliferation, stress-induced premature senescence and the self-renewal of stem cells (Fontana et al., 2008; Ivanovska et al., 2008; Petrocca et al., 2008; Inomata et al., 2009; Li et al., 2009; Chen et al., 2010; Wong et al., 2010) . The post-transcriptional regulation of p21 by the embryonic stem cell-specific miRNAs, miR-290 cluster, was shown to promote the G1/S transition and rapid proliferation of embryonic stem cells (Wang et al., 2008) . The Kaposi's sarcomaassociated herpes virus miR-K1 represses the expression of p21 and attenuates p21-mediated cell cycle arrest (Gottwein and Cullen, 2010) . A number of miRNAs, such as miR-302a, miR-146a and miR-146b, which target p21 can rescue human mammary epithelial cells from Ras G12V -induced senescence by preventing the Ras G12V -induced upregulation of p21 (Borgdorff et al., 2010) . A screening strategy identified 28 miRNAs that can suppress p21 expression by directly targeting its 3 0 UTRs and some of them were verified to promote cell proliferation and cell cycle progression (Wu et al., 2010) . In the present study, we provide evidence that miR-663, by targeting p21 and causing the aberrant transition from the G1 to the S phase, promoted cell proliferation and tumorigenicity in NPC cells.
Although we showed that miR-663 could function as oncogenic miRNA through the molecular axis miR-663/ p21 in NPC cell lines in vitro and our animal model in vivo, the inverse correlation between miR-663 and p21 expression was not detectable in the same NPC/ nasopharingitis tissues. This inconsistence may be due to the complicated regulation of p21. For instance, Lei et al. (1999) reported that the positive expression rates of p21 were different between the NPC tissues and nontumor nasopharyngeal tissue; (45.7 vs 80.0%), whereas Wang et al. (2005) reported that the expression level of p21 were indistinguishable between the NPC tissues and the chronic inflammatory nasopharyngeal mucosa. In fact, p21 is tightly regulated at multiple levels. First, p21 is controlled by p53-dependent and -independent mechanisms at the transcriptional level (el-Deiry et al., 1994; Parker et al., 1995) . Second, the p21 mRNA stability was regulated by miRNAs and the RNAbinding protein (Joseph et al., 1998; Filipowicz et al., 2008) . Third, p21 is also regulated by phosphorylation and ubiquitination at the post-translational level (Li et al., 1996; Zhou et al., 2001; Child and Mann, 2006) . For example, as mentioned above, there are multiple miRNAs directly regulated p21 in the literature. Notably, various factors, such as the EBV nuclear antigen 2 and lactotransferrin, have been reported to regulate p21 in NPC (Lin et al., 2000; Zhou et al., 2008) .
Chemically modified antisense oligonucleotides are widely used as miRNA inhibitors, such as 2 0 O-methyl, LNA (Hutvagner et al., 2004; Meister et al., 2004; Orom et al., 2006) , which only provide a correspondingly transient derepression of miRNA targets in cells. Artificial miRNA decoys termed 'miRNA sponges' were recently introduced as a long-term inhibitor that can stably block the function of miRNAs in cell lines and transgenic organisms (Ebert et al., 2007) . This approach has proved to be a useful tool to probe miRNA functions in a variety of experimental systems, such as models of breast cancer and glioma (Valastyan et al., 2009; Mei et al., 2011) . In the present experimental model, we structured a miR-663 sponge to block miR-663 stably in NPC cells in a stronger way than with LNA, in accordance with the report by Ebert et al. (2007) Therefore, we speculate that 'miRNA sponges' can be used as a powerful tool to investigate the functions of miRNAs and as a potential therapeutic strategy by targeting miRNAs. However, it is worth noting that the most appropriate dose of sponges that should be used is yet to be determined due to their high cytotoxicity (data not shown).
In summary, expression profiling and functional studies suggest an important role of miR-663 in the molecular etiology of oncology. For the first time, we have revealed that miR-663 has oncogenic functions in NPC. The newly identified miR-663/p21 axis sheds light on the molecular mechanism of NPC cell proliferation. It is logical to predict that the inhibition of miR-663 may serve as a basis for the development of a potentially new therapeutic regimen against NPC.
Materials and methods
Cell culture
Two human immortalized nasopharyngeal epithelial cell lines (NP69 and N5-Bmi-1) were grown in keratinocyte/serum-free medium supplemented with growth factors (Gibco, Grand Island, NY, USA; Li et al., 2004; Liao et al., 2005; Song et al., 2006 Song et al., , 2009 . One EBV latently infected NPC cell line (HONE1), one well-differentiated NPC cell line (CNE1), three poorly differentiated NPC cell lines (CNE2, C666 and SUNE1) and two SUNE1 subclones (6-10B and 5-8F) were cultured in RPMI-1640 supplemented with 10% fetal bovine serum (Glaser et al., 1989; Liao et al., 2005; Song et al., 2006 Song et al., , 2009 Kong et al., 2010) . Two human gastric cancer cell lines (MKN-45 and SCG-7901; provided by Jun Li, Department of Biochemistry, Sun Yat-sen University School of Medicine, Guangzhou, China) were cultured in RPMI-1640 supplemented with 10% fetal bovine serum. Cells were maintained in a 5% CO 2 incubator at 37 1C.
Tissue samples A total of 12 samples of NPC tissues were biopsied from masses in nasopharyngeal cavities of 12 patients with NPC and diagnosed pathologically as undifferentiated non-keratinizing carcinoma. Again, 12 samples of nasopharyngitis tissues were biopsied from mucosa in nasopharyngeal cavities of 12 patients with chronic nasopharyngitis. The 24 tissue samples were formalin-fixed and paraffin-embedded. The patients gave informed consent before the tissue sampling and the research protocols were approved by the Sun Yat-sen University Cancer Center Institute Research Ethics Committee.
Vector construction psiCHECK-2, a firefly luciferase-expressing vector, was used in the luciferase reporter assay. To construct the psiCHECK2-p21-3 0 UTR-wt plasmid, a wild-type 3 0 UTR segment of p21 mRNA that contained the putative miR-663-binding sites was amplified and cloned into the PmeI and NotI sites downstream of the luciferase reporter gene in psiCHECK-2. psiCHECK-2-p21UTR-mt1 and psiCHECK-2-p21UTR-mt2 each carried the mutated sequence in one of the two miR-663-binding sites, respectively, whereas psiCHECK-2-p21UTR-mt3 contained mutations of both the miR-663-binding sites.
To construct a sponge-miR-663 plasmid vector, we inserted tandemly arrayed miR-663-binding sites into a enhance green fluorescent protein vector (pEGFP-C2). The sponge-C1 plasmid vectors were constructed as the negative control, with a tandemly arrayed sequence of Caenorhabditis elegans gene (cel-miR-239b) instead of the miR-663-binding sites.
P21 complementary DNA lacking its 3 0 UTR (3 0 UTR-less p21) or carrying a wild-type 3 0 UTR expression cassette at miR-663 response element were cloned into pcDNA 3.1 for 'rescue' experiments.
miRNA microarray Total RNA samples were isolated from nasopharyngeal epithelial cells (N5-Bmi-1) and NPC cells (HONE1 and 5-8F) using Trizol reagent (Invitrogen, Carlsbad, CA, USA).
Approximately, 5 mg of total RNA from each sample were biotin-labeled by reverse transcription using 5 0 -biotin endlabeled random octomer oligo primers. Hybridization of biotin-labeled cDNA was carried out on a miRNA microarray chip, which contained 686 miRNA oligo probes printed in duplicate. Hybridization signals were scanned with a LuxScan3.0 scanner (Capital Bio. Corporation, Beijing, China). The resultant images were digitized with Genepix Pro 6.0 software (Axon Instruments, Foster City, CA, USA).
RT-PCR and quantitative real-time RT-PCR For mRNA and miRNA analyses, total RNA was purified with Trizol Reagent (Invitrogen). cDNA was synthesized using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI, USA). The expression levels of mature miRNAs were determined by SYBR Green quantitative PCR amplifications performed on the Stratagene Mx3000P RealTime PCR system (Agilent Technologies, Inc., Santa Clara, CA, USA). The primers used for PCR amplification were as follows: forward, The fold-changes for miRNA expression levels were calculated using 2
ÀDDCt .
Transient transfection
Asynchronously growing cells were seeded at 2 Â 10 5 cells/well of a six-well plate format. Transfection of cells with 100 nM pre-miR-663, 100 nM LNA anti-miR or 50 nM p21 siRNA was performed using Lipofectamine RNAiMAX (Invitrogen).
Stable transfection CNE1 and 5-8F cells were transfected with miR-663 sponge or control sponge-C1 plasmid vectors to generate stable cells that lacked miR-663 or control cells, respectively. Transfected CNE1 and 5-8F cells were selected with G418 (Merck & Co. Inc., Whitehouse Station, NJ, USA) at 350 mg/ml for 4 weeks. The stable cell clones were obtained and maintained in G418 at 150 mg/ml.
Cell proliferation assay
Cells were plated at 1500 cells/well in 96-well plates. After transfection, the cells were cultured for 1, 2, 3, 4 and 5 days. On the indicated days, MTT reagent (AMRESCO, Solon, OH, USA) was added and incubated for 3 h at 37 1C. The supernatant was discarded and replaced with dimethyl sulfoxide to dissolve the formazan product. Absorbance was measured at an optical density of 490 nm in a spectrophotometric plate reader.
Analysis of cell clonogenicity
After transfection, 500 cells were placed in six-well plates and maintained in complete medium for 2 weeks. Colonies were fixed with methanol, stained with 0.1% crystal violet and counted.
Tumorigenicity assay in nude mice
Five-week-old nude BALB/c athymic strain mice were subcutaneously injected in the right flank with 4 Â 10 6 CNE1 cells that stably expressed the miR-663 sponge or control sponge vector (CNE1-sponge-663 or CNE1-NC). Tumor growth was examined every 3 days for 6 weeks. Tumor volume (V) was monitored by measuring the length (L) and width (W) of the tumors and calculated with the following equation: V ¼ (L Â W 2 ) Â 0.5.
Synchronization
Cells were synchronized with serum deprivation for 48 h and then released into the S-phase by the re-addition of serum. Cells were harvested at the indicated time points.
Cell cycle analysis
At 48 h post-transfection, cells were collected and fixed with 70% ethanol at 4 1C overnight. Cells were washed and then stained with propidium iodide for 30 min at 37 1C. Cells were analyzed for DNA content by flow cytometry (fluorescenceactivated cell sorting) using a Cytomics FC 500 (Beckman Coulter, Brea, CA, USA). Data were analyzed with the Multicycle AV for Windows software (Beckman Coulter).
Luciferase reporter assay
For the luciferase reporter assay, 293T cells co-transfected with 20 mM of either pre-miR-663 or the negative control, and 500 ng of psiCHECK2-p21-3 0 UTR-wt, psiCHECK-2-p21UTR-mt1, psiCHECK-2-p21UTR-mt2 or psiCHECK-2-p21UTR-mt3, using Lipofectamine 2000 (Invitrogen). Cells were collected 48 h after transfection and analyzed using the Dual-Luciferase Reporter Assay System (Promega). Luciferase activity was detected by the GloMax fluorescence reader (Promega). The psiCHECK-2 vector that provided the constitutive expression of Renilla luciferase was co-transfected as an internal control.
Western blot
Whole cell proteins were separated in 12% SDS-PAGE gels and blotted on nitrocellulose membranes. The filters were hybridized with polyclonal anti-p21, anti-ppRb, anti-pRb, anti-E2F1, anti-cyclin E, anti-cyclin A and anti-p27 (Cell Signaling Technology, Danvers, MA, USA) at 4 1C overnight, followed by incubation with the secondary anti-rabbit or antimouse (Santa Cruz Biotechnology, CA, USA) for 1 h at room temperature. Anti-GAPDH (Santa Cruz Biotechnology) was used as the loading control.
Confocol microscopy
Cells grown on coverslips were fixed using 4% paraformaldehyde solution for 15 min. Samples were blocked for 30 min with 5% bovine serum albumin/phosphate-buffered saline at room temperature and then incubated with primary antibody (1:50 anti-p21; Cell Signaling Technology) at 4 1C overnight. The coverslips were incubated with the secondary anti-rabbit antibody (Invitrogen) for 1 h at room temperature in the dark and stained with 4-,6-diamidino-2-phenylindole (Invitrogen) for 5 min to visualize the nuclei. The coverslips were mounted onto glass slides and visualized by confocal microscopy.
Immunohistochemistry Immunohistochemistry was performed as described previously (Yun et al., 2007; Zhang et al., 2009) . Briefly, after blocking, the sections were incubated with primary antibodies overnight (antip21 (Cell Signaling Technology), 1:25; anti-Ki67 (Santa Cruz Biotechnology), 1:1), followed by incubation with secondary antibodies, and further incubation with the Streptavidin-Biotin complex (Dakopatts, Glostrup, Denmark). Reactivity was developed in chromogen 3,3 0 -diaminobenzidine (DAB) solution. After contrast staining, the sections were dehydrated and mounted. A brown particle in a cell was considered as positive labeling.
Statistical analysis
Data are presented as means ± s.d. from at least three separate experiments. Unless otherwise noted, the Student's t-test was used for comparisons between groups. Differences were considered significant for P-values less than 0.05.
